Manufacturing Processes of a Purified Microbiome Therapeutic Reduce Risk of Transmission of Potential Bacterial Pathogens in Donor Stool.
Journal Information
Full Title: J Infect Dis
Abbreviation: J Infect Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Communicable Diseases
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Potential conflicts of interest. C. W. J. M., M.-J. L., B. H. M., J. G. A., E. H., S. A., B. R. H., and D. S. E. are current employees and shareholders of Seres Therapeutics. G. J. M. and B. S. are former employees of Seres Therapeutics. S. K. receives research support from Rebioitx/Ferring, Vedanta, Finch, Seres, and Pfizer; and serves as a consultant for ProbioTech, Takeda, Niche, and Immuron.: All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed."
"Financial support. This work was supported by Seres Therapeutics. Financial support."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025